Related Experiment Videos
The Li+/Na+ exchange in hypertension
Andrea Semplicini1, Michelangelo Sartori, Giulio Ceolotto
1Clinica Medica 4, Department of Clinical and Experimental Medicine, University of Padova Medical School, Italy. andrea.semplicini@unipd.it
Frontiers in Bioscience : a Journal and Virtual Library
|April 18, 2003
Summary
Red blood cell lithium-sodium (Li+/Na+) exchange is elevated in hypertension and related conditions. This cellular marker may indicate increased cardiovascular risk and aid in identifying individuals at risk for diabetic nephropathy.
Area of Science:
- Biochemistry
- Cell Biology
- Cardiovascular Research
Background:
- Red blood cell membrane Li+/Na+ exchange is a 1:1 stoichiometric heteroexchange mechanism.
- This exchange process is unimodally distributed in the general population, skewed rightward due to superimposed normal distributions.
- Elevated red cell Li+/Na+ exchange is consistently observed in patients with essential hypertension compared to normotensive controls.
Purpose of the Study:
- To investigate the role of red cell Li+/Na+ exchange as a potential biomarker.
- To explore the association of Li+/Na+ exchange with hypertension and related clinical conditions.
- To assess its utility as a cellular marker for cardiovascular risk and diabetic nephropathy.
Main Methods:
- Comparative analysis of red cell Li+/Na+ exchange rates between hypertensive and normotensive individuals.
- Investigation of Li+/Na+ exchange levels in patients with overweight, diabetes, and associated complications.
- Correlation analysis between Li+/Na+ exchange and clinical parameters such as insulin resistance, obesity, and cardiovascular history.
Main Results:
- Red cell Li+/Na+ exchange is significantly increased in patients with essential hypertension.
- Elevated exchange rates are also found in overweight and diabetic individuals, particularly those with nephropathy, hypertension, and microalbuminuria.
- High Li+/Na+ exchange is associated with severe/drug-resistant hypertension, insulin resistance, vascular/cardiac hypertrophy, hyperlipidemia, obesity, and a history of cardiovascular events.
Conclusions:
- Increased red cell Li+/Na+ exchange is a validated finding in hypertension and related conditions.
- It serves as a potential cellular marker for increased cardiovascular risk.
- Measurement of Li+/Na+ exchange may offer clinical utility as an intermediate phenotype for assessing cardiovascular risk, especially in diabetic patients at risk for nephropathy.